Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met

References

• Altaf M, Miller CH, Bellows DS, O'Toole R. 2010. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors. Tuberculosis (Edinb). 90:333–337.
   PubMed Web of Science ®Google Scholar
• Anand PK, Kaul D, Sharma M. 2006. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. Int J Biochem Cell Biol. 38:600–609.
   PubMed Web of Science ®Google Scholar
• Aponte JC, Estevez Y, Gilman RH, Lewis WH, Rojas R, Sauvain M, Vaisberg AJ, Hammond GB. 2008. Anti-infective and cytotoxic compounds present in Blepharodon nitidum. Planta Med. 74:407–410.
   PubMed Web of Science ®Google Scholar
• Bai B, Xie JP, Yan JF, Wang H, Hu CH. 2006. A high throughput screening approach to identify isocitrate lyase inhibitors from traditional Chinese medicine sources. Drug Dev Res. 67:818–823.
   Web of Science ®Google Scholar
• Bai X, Oberley-Deegan RE, Bai A, Ovrutsky AR, Kinney WH, Weaver M, Zhang G, Honda JR, Chan ED. 2016. Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection. Respirology. 21:951–957.
   PubMed Web of Science ®Google Scholar
• Bapela NB, Lall N, Fourie PB, Franzblau SG, Van Rensburg CEJ. 2006. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis. Phytomedicine. 13:630–635.
   PubMed Web of Science ®Google Scholar
• Barry CE, III, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, Schnappinger D, Wilkinson RJ, Young D. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 7:845–855.
   PubMed Web of Science ®Google Scholar
• Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 43:717–731.
   PubMed Web of Science ®Google Scholar
• Caminero JA, Sotgiu G, Zumla A, Migliori GB. 2010. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 10:621–629.
   PubMed Web of Science ®Google Scholar
• Changtam C, Hongmanee P, Suksamrarn A. 2010. Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. Eur J Med Chem. 45:4446–4457.
   PubMed Web of Science ®Google Scholar
• Chaturvedi V, Dwivedi N, Tripathi RP, Sinha S. 2007. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis. J Gen Appl Microbiol. 53:333–337.
   PubMed Web of Science ®Google Scholar
• Chawla PC. 2010. Resorine A novel CSIR drug curtails TB treatment. CSIR News. 60:52–54.
   Google Scholar
• Chen JJ, Chou ET, Peng CF, Chen IS, Yang SZ, Huang HY. 2007. Novel epoxyfuranoid lignans and antitubercular constituents from the leaves of Beilschmiedia tsangii. Planta Med. 73:567–571.
   PubMed Web of Science ®Google Scholar
• Cho SH, Warit S, Wan B, Hwang CH, Pauli GF, Franzblau SG. 2007. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother. 51:1380–1385.
   PubMed Web of Science ®Google Scholar
• Collins LA, Torrero MN, Franzblau SG. 1998. Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 42:344–347.
   PubMed Web of Science ®Google Scholar
• Deb C, Lee CM, Dubey VS, Daniel J, Abomoelak B, Sirakova TD, Pawar S, Rogers L, Kolattukudy PE. 2009. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One. 4:e6077.
   PubMed Web of Science ®Google Scholar
• Elkington BG, Sydara K, Newsome A, Hwang CH, Lankin DC, Simmler C, Napolitano JG, Ree R, Graham JG, Gyllenhaal C, et al. 2014. New finding of an anti-TB compound in the genus Marsypopetalum (Annonaceae) from a traditional herbal remedy of Laos. J Ethnopharmacol. 151:903–911.
   PubMed Web of Science ®Google Scholar
• Eloff JN. 1998. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol. 60:1–8.
   PubMed Web of Science ®Google Scholar
• Esquivel-Ferriño PC, Favela-Hernández JM, Garza-González E, Waksman N, Ríos MY, del Rayo CM. 2012. Antimycobacterial activity of constituents from Foeniculum vulgare var. dulce grown in Mexico. Molecules. 17:8471–8482.
   PubMed Web of Science ®Google Scholar
• Fattorini L, Piccaro G, Mustazzolu A, Giannoni F. 2013. Targeting dormant bacilli to fight tuberculosis. Mediterr J Hematol Infect Dis. 5:e2013072.
   PubMedGoogle Scholar
• Favela-Hernández JM, García A, Garza-González E, Rivas-Galindo VM, Camacho-Corona MR. 2012. Antibacterial and antimycobacterial lignans and flavonoids from Larrea tridentata. Phytother Res. 26:1957–1960.
   PubMed Web of Science ®Google Scholar
• Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH, et al. 2010. HIV coinfection in multidrug and extensively drug resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 181:80–86.
   PubMed Web of Science ®Google Scholar
• Gautam R, Saklani A, Jachak SM. 2007. Indian medicinal plants as a source of antimycobacterial agents. J Ethnopharmacol. 110:200–234.
   PubMed Web of Science ®Google Scholar
• Ge F, Zeng F, Liu S, Guo N, Ye H, Song Y, Fan J, Wu X, Wang X, Deng X, et al. 2010. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis. J Med Microbiol. 59:567–572.
   PubMed Web of Science ®Google Scholar
• Gómez-Cansino R, Espitia-Pinzón CI, Campos-Lara MG, Guzmán-Gutiérrez SL, Segura-Salinas E, Echeverría-Valencia G, Torras-Claveria L, Cuevas-Figueroa XM, Reyes-Chilpa R. 2015. Antimycobacterial and HIV-1 reverse transcriptase activity of Julianaceae and Clusiaceae plant species from Mexico. Evid Based Complement Alternat Med. 2015:183036.
   PubMedGoogle Scholar
• Gordien AY, Gray AI, Franzblau SG, Seidel V. 2009. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae). J Ethnopharmacol. 126:500–505.
   PubMed Web of Science ®Google Scholar
• Greco WR, Bravo G, Parsons JC. 1995. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev. 47:331–385.
   PubMed Web of Science ®Google Scholar
• Guo N, Wu J, Fan J, Yuan P, Shi Q, Jin K, Cheng W, Zhao X, Zhang Y, Li W, et al. 2014. In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis. Lett Appl Microbiol. 58:344–349.
   PubMed Web of Science ®Google Scholar
• Gupta A, Bhakta S. 2012. An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis. J Antimicrob Chemother. 67:1380–1391.
   PubMed Web of Science ®Google Scholar
• Gupta P, Bhatter P, D’souza D, Tolani M, Daswani P, Tetali P, Birdi T. 2014. Evaluating the anti Mycobacterium tuberculosis activity of Alpinia galanga (L.) Willd. axenically under reducing oxygen conditions and in intracellular assays. BMC Complement Altern Med. 14:84.
   PubMed Web of Science ®Google Scholar
• Gupta R, Thakur B, Singh P, Singh HB, Sharma VD, Katoch VM, Chauhan SV. 2010. Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates. Indian J Med Res. 131:809–813.
   PubMed Web of Science ®Google Scholar
• Gupta VK, Shukla C, Bisht GR, Saikia D, Kumar S, Thakur RL. 2011. Detection of anti-tuberculosis activity in some folklore plants by radiometric BACTEC assay. Lett Appl Microbiol. 52:33–40.
   PubMed Web of Science ®Google Scholar
• Helfer M, Koppensteiner H, Schneider M, Rebensburg S, Forcisi S, Müller C, Schmitt-Kopplin P, Schindler M, Brack-Werner R. 2014. The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor. PLoS One. 9:e87487.
   PubMed Web of Science ®Google Scholar
• Huffman MA. 2003. Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants. Proc Nutr Soc. 62:371–382.
   PubMed Web of Science ®Google Scholar
• Ignacimuthu S, Shanmugam N. 2010. Antimycobacterial activity of two natural alkaloids, vasicine acetate and 2-acetyl benzylamine, isolated from Indian shrub Adhatoda vasica Ness leaves. J Biosci. 35:565–570.
   PubMed Web of Science ®Google Scholar
• Jimenez-Arellanes A, Meckes M, Ramirez R, Torres J, Luna-Herrera J. 2003. Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases. Phytother Res. 17:903–908.
   PubMed Web of Science ®Google Scholar
• Jimenez-Arellanes A, Meckes M, Alvarez V, Torres J, Parra R. 2005. Secondary metabolites from Chamaedora tepejilote (Palmae) are active against Mycobacterium tuberculosis. Phytother Res. 19:320–322.
   PubMed Web of Science ®Google Scholar
• Jimenez-Arellanes A, Meckes M, Ramirez R, Torres J, Luna-Herrera J. 2007. Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae). J Ethnopharmacol. 111:202–225.
   PubMed Web of Science ®Google Scholar
• Jiménez-Arellanes A, León-Díaz R, Meckes M, Tapia A, Molina-Salinas GM, Luna-Herrera J, Yépez-Mulia L. 2012. Antiprotozoal and antimycobacterial activities of pure compounds from Aristolochia elegans rhizomes. Evid Based Complement Alternat Med. 2012:593403.
   PubMed Web of Science ®Google Scholar
• Jiménez-Arellanes A, Luna-Herrera J, Cornejo-Garrido J, López-García S, Castro-Mussot ME, Meckes-Fischer M, Mata-Espinosa D, Marquina B, Torres J, Hernández-Pando R. 2013. Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment. BMC Complement Altern Med. 13:258.
   PubMed Web of Science ®Google Scholar
• Jyoti MA, Nam KW, Jang WS, Kim YH, Kim SK, Lee BE, Song HY. 2016. Antimycobacterial activity of methanolic plant extract of Artemisia capillaris containing ursolic acid and hydroquinone against Mycobacterium tuberculosis. J Infect Chemother. 22:200–2008.
   PubMed Web of Science ®Google Scholar
• Kim CE, Griffiths WJ, Taylor PW. 2009. Components derived from Pelargonium stimulate macrophage killing of Mycobacterium species. J Appl Microbiol. 106:1184–1193.
   PubMed Web of Science ®Google Scholar
• Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. 2011. The challenge of new drug discovery for tuberculosis. Nature. 469:483–490.
   PubMed Web of Science ®Google Scholar
• Kumar P, Singh A, Sharma U, Singh D, Dobhal MP, Singh S. 2013. Anti-mycobacterial activity of plumericin and isoplumericin against MDR Mycobacterium tuberculosis. Pulm Pharmacol Ther. 26:332–335.
   PubMed Web of Science ®Google Scholar
• Labuschagné A, Hussein AA, Rodríguez B, Lall N. 2012. Synergistic antimycobacterial actions of Knowltonia vesicatoria (L.f) Sims. Evid Based Complement Alternat Med. 2012:808979.
   PubMedGoogle Scholar
• Lakshmanan D, Werngren J, Jose J, Suja KP, Nair MS, Varma RL, Mundayoor S, Hoffner S, Kumar RA. 2011. Ethyl p-methoxycinnamate isolated from a traditional anti-tuberculosis medicinal herb inhibits drug resistant strains of Mycobacterium tuberculosis in vitro. Fitoterapia. 82:757–761.
   PubMed Web of Science ®Google Scholar
• Lall N, Meyer JJM. 2001. Inhibition of drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis by diospyrin, isolated from Euclea natalensis. J Ethnopharmacol. 78:213–216.
   PubMed Web of Science ®Google Scholar
• Lall N, Meyer JJM, Wang Y, Bapela NB, van Rensburg CEG, Fourie B, Franzblau SG. 2005. Characterization of intracellular activity of antitubercular constituents the roots of Euclea natalensis. Pharm Biol. 43:353–357.
   PubMed Web of Science ®Google Scholar
• Lee YV, Wahab HA, Choong YS. 2015. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary. Biomed Res Int. 2015:895453.
   PubMed Web of Science ®Google Scholar
• León-Díaz R, Meckes M, Said-Fernández S, Molina-Salinas GM, Vargas-Villarreal J, Torres J, Luna-Herrera J, Jiménez-Arellanes A. 2010. Antimycobacterial neolignans isolated from Aristolochia taliscana. Mem Inst Oswaldo Cruz. 105:45–51.
   PubMed Web of Science ®Google Scholar
• Liang J, Zeng F, Guo A, Liu L, Guo N, Li L, Jin J, Wu X, Liu M, Zhao D, et al. 2011. Microarray analysis of the chelerythrine-induced transcriptome of Mycobacterium tuberculosis. Curr Microbiol. 62:1200–1208.
   PubMed Web of Science ®Google Scholar
• Lin PL, Flynn JL. 2010. Understanding latent tuberculosis: a moving target. J Immunol. 185:15–22.
   PubMed Web of Science ®Google Scholar
• Luo X, Pires D, Aínsa JA, Gracia B, Duarte N, Mulhovo S, Anes E, Ferreira MJ. 2013. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages. J Ethnopharmacol. 146:417–422.
   PubMed Web of Science ®Google Scholar
• Martin A, Camacho M, Portaels F, Palomino JC. 2003. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother. 47:3616–3619.
   PubMed Web of Science ®Google Scholar
• Mativandlela SPN, Muthivhi T, Kikuchi H, Oshima Y, Hamilton C, Hussein AA, van der Walt ML, Houghton PJ, Lall N. 2009. Antimycobacterial flavonoids from the leaf extract of Galenia africana. J Nat Prod. 72:2169–2171.
   PubMed Web of Science ®Google Scholar
• McKinney JD, Höner zu BK, Muñoz-Elías EJ, Miczak A, Chen B, Chan WT, Swenson D, Sacchettini JC, Jacobs WR, Jr, Russell DG. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature. 406:735–738.
   PubMed Web of Science ®Google Scholar
• Mehta A, Srivastva G, Kachhwaha S, Sharma M, Kothari SL. 2013. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates. J Ethnopharmacol. 149:195–200.
   PubMed Web of Science ®Google Scholar
• Molina-Salinas GM, Bórquez J, Ardiles A, Said-Fernández S, Loyola LA, San-Martin A, González-Collado I, Peña-Rodríguez LM. 2010. Antituberculosis activity of natural and semisynthetic azorellane and mulinane diterpenoids. Fitoterapia. 81:50–54.
   PubMed Web of Science ®Google Scholar
• Navarro-García VM, Luna-Herrera J, Rojas-Bribiesca MG, Álvarez-Fitz P, Ríos MY. 2011. Antibacterial activity of Aristolochia brevipes against multidrug-resistant Mycobacterium tuberculosis. Molecules. 16:7357–7364.
   PubMed Web of Science ®Google Scholar
• Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Masyuk LA, Kutsyna GA. 2008. Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS. Int Immunopharmacol. 8:845–851.
   PubMed Web of Science ®Google Scholar
• Odds FC. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 52:1.
   PubMed Web of Science ®Google Scholar
• O'Neill TE, Li H, Colquhoun CD, Johnson JA, Webster D, Gray CA. 2014. Optimisation of the microplate resazurin assay for screening and bioassay-guided fractionation of phytochemical extracts against Mycobacterium tuberculosis. Phytochem Anal. 25:461–467.
   PubMed Web of Science ®Google Scholar
• Pan SY, Zhou SF, Gao SH, Yu ZL, Zhang SF, Tang MK, Sun JN, Ma DL, Han YF, Fong WF, et al. 2013. New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics. Evid Based Complement Alternat Med. 2013:627375.
   PubMed Web of Science ®Google Scholar
• Pauli GF, Case RJ, Inui T, Wang Y, Cho S, Fischer NH, Franzblau SG. 2009. New perspectives on natural products in TB drug research. Life Sci. 78:485–494.
   Google Scholar
• Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. 2012. Tuberculosis and HIV co-infection. PLoS Pathog. 8:e1002464.
   PubMed Web of Science ®Google Scholar
• Phelan J, Maitra A, McNeney R, Nair M, Gupta A, Coll F, Pain A, Bhakta S, Clark TG. 2015. The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae. Int J Mycobacteriol. 4:207–216.
   PubMed Web of Science ®Google Scholar
• Prihoda ND, Arjanova OV, Yurchenko LV, Sokolenko NI, Vihrova LA, Pylypchuk VS, Frolov VM, Kutsyna GA. 2009. Adjuvant immunotherapy of extensively drug-resistant tuberculosis (XDR-TB) in Ukraine. Current Res Tuberculosis. 1:9–14.
   Google Scholar
• Rijo P, Simões MF, Francisco AP, Rojas R, Gilman RH, Vaisberg AJ, Rodríguez B, Moiteiro C. 2010. Antimycobacterial metabolites from Plectranthus royleanone derivatives against Mycobacterium tuberculosis strains. Chem Biodivers. 7:922–932.
   PubMed Web of Science ®Google Scholar
• Rios JL, Recio MC. 2005. Medicinal plants and antimicrobial activity. J Ethnopharmacol. 100:80–84.
   PubMed Web of Science ®Google Scholar
• Rojas R, Caviedes L, Aponte JC, Vaisberg AJ, Lewis WH, Lamas G, Sarasara C, Gilman RH, Hammond GB. 2006. Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera. J Nat Prod. 69:845–846.
   PubMed Web of Science ®Google Scholar
• Santhosh RS, Suriyanarayanan B. 2014. Plants: a source for new antimycobacterial drugs. Planta Med. 80:9–21.
   PubMed Web of Science ®Google Scholar
• Sharma S, Kumar M, Sharma S, Nargotra A, Koul S, Khan IA. 2010. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J Antimicrob Chemother. 65:1694–1701.
   PubMed Web of Science ®Google Scholar
• Sharma S, Kalia NP, Suden P, Chauhan PS, Kumar M, Ram AB, Khajuria A, Bani S, Khan IA. 2014. Protective efficacy of piperine against Mycobacterium tuberculosis. Tuberculosis (Edinb). 94:389–396.
   PubMed Web of Science ®Google Scholar
• Silva ACO, Santana EF, Saraiva AM, Coutinho FN, Castro RHA, Pisciottano MNC, Amorim ELC, Albuquerque UP. 2013. Which approach is more effective in the selection of plants with antimicrobial activity? Evid Based Complement Alternat Med. 2013:308980.
   PubMedGoogle Scholar
• Songsri S, Nuntawong N. 2016. Cytotoxic labdane diterpenes from Hedychium ellipticum Buch.-Ham. ex Sm. Molecules. 21:749.
   Web of Science ®Google Scholar
• Sureram S, Senadeera SPD, Hongmanee P, Mahidol C, Ruchirawat S, Kittakoop P. 2012. Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis. Bioorg Med Chem Lett. 22:2902–2905.
   PubMed Web of Science ®Google Scholar
• Torres-Romero D, Jiménez IA, Rojas R, Gilman RH, López M, Bazzocchi IL. 2011. Dihydro-β-agarofuran sesquiterpenes isolated from Celastrus vulcanicola as potential anti-Mycobacterium tuberculosis multidrug-resistant agents. Bioorg Med Chem. 19:2182–2189.
   PubMed Web of Science ®Google Scholar
• Uc-Cachón AH, Borges-Argáez R, Said-Fernández S, Vargas-Villarreal J, González-Salazar F, Méndez-González M, Cáceres-Farfán M, Molina-Salinas GM. 2014. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains. Pulm Pharmacol Ther. 27:114–120.
   PubMed Web of Science ®Google Scholar
• van de Venter M, Pruissen M, Koekemoer T, Sowemimo A, Govender S. 2014. In vitro anti-HIV and -TB activities of Annona muricata and Artemisia afra extracts. Planta Med. 80:P1L29.
   Web of Science ®Google Scholar
• Wayne LG, Hayes LG. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of non replicating persistence. Infect Immun. 64:2062–2069.
   PubMed Web of Science ®Google Scholar
• Wayne LG, Sramek HA. 1994. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 38:2054–2058.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2002-2005. Traditional Medicine Strategy.
   Google Scholar
• World Health Organization. 2016a. Global tuberculosis report.
   Google Scholar
• World Health Organization. 2016b. MDR TB fact sheet.
   Google Scholar
• Xu ZQ, Barrow WW, Suling WJ, Westbrook L, Barrow E, Lin YM, Flavin MT. 2004. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis. Bioorg Med Chem. 12:1199–1207.
   PubMed Web of Science ®Google Scholar
• Zaitzeva SI, Matveeva SL, Gerasimova TG, Pashkov YN, Butov DA, Pylypchuk VS, Frolov VM, Kutsyna GA. 2009. Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo. Clin Microbiol Infect. 15:1154–1162.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yew WW. 2015. Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015. Int J Tuberc Lung Dis. 19:1276–1289.
   PubMed Web of Science ®Google Scholar